Trial intelligence / Profile preview

Fast awakening from general anesthesia with naloxone in healthy volunteers

NL-OMON58709Phase 4Not yet recruiting

Sponsor
Radboud University Medical Center
Start
Jan 2026
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of naloxone, sponsored by Radboud University Medical Center. Primary endpoint: Time to return of spontaneous breathing. Planned start Jan 2026; status: not yet recruiting.

02

Drugs

naloxone

Beyond the preview

Go deeper on NL-OMON58709.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON58709.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call